Hector Jose S. P.
- Country
- Italy
- Department
- 4106: Oncologia Medica
Research Overview
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
- Phase II Study of Rilvegostomig and Ramucirumab in Combination Therapy for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 305 of 598 partner sites.
Specializations
Lung Cancer Research
Specializes in investigating innovative treatments for non-small cell lung cancer (NSCLC), with particular focus on patients with specific genetic mutations including EGFR mutations and ALK-positive cases.
- Advanced and Metastatic NSCLC
- EGFR Exon 20 Insertion Mutations
- Targeted Combination Therapies
Investigates novel therapeutic approaches including targeted treatments and immunotherapy combinations for lung cancer patients.
Urological Oncology
Conducts research in bladder cancer treatment, particularly focusing on muscle-invasive bladder cancer and advanced urothelial carcinoma.
- Perioperative Immunotherapy
- Advanced Urothelial Cancer
- Combination Treatment Approaches
Explores innovative therapeutic strategies combining surgery with immunotherapy and targeted treatments.
Specialized Therapeutic Areas
Investigates treatments for various conditions including vasomotor symptoms in breast cancer patients and head and neck squamous cell carcinoma.
- Hormone Therapy-Related Symptoms
- Recurrent/Metastatic Head and Neck Cancer
- Novel Therapeutic Combinations
Focuses on developing treatments for cancer-related conditions and improving patient outcomes through targeted approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.